about
Everolimus restrains the paracrine pro-osteoclast activity of breast cancer cells.Physiology of incretins and loss of incretin effect in type 2 diabetes and obesity.Interval sentinel lymph nodes in melanoma: a digital pathology analysis of Ki67 expression and microvascular density.β-catenin interaction with NHERF1 and RASSF1A methylation in metastatic colorectal cancer patientsNHERF1 together with PARP1 and BRCA1 expression as a new potential biomarker to stratify breast cancer patients.Hierarchical clustering analysis identifies metastatic colorectal cancers patients with more aggressive phenotype.T cells, mast cells and microvascular density in diffuse large B cell lymphoma.Dissection of DLBCL Microenvironment Provides a Gene Expression-Based Predictor of Survival Applicable to Formalin-Fixed Paraffin-Embedded TissueShould Tumor Infiltrating Lymphocytes, Androgen Receptor, and FOXA1 Expression Predict the Clinical Outcome in Triple Negative Breast Cancer Patients?
P50
Q35807838-2704C73C-BD2D-4AB3-B3AC-D4CF62665610Q38122004-E201810B-59BA-45E7-9321-9AD0B96F2D5BQ40305491-59CC3FE8-E69A-49B6-82F7-EA74326E01C2Q42315542-88DAAF5D-F9BC-4302-85AE-551DF5E3F8A3Q42371576-C9A4324A-A92C-41D5-930F-70E789E200DEQ47122868-AFCF9DED-5737-4A20-A75E-99F918F63F3FQ53513499-A3CBFE47-9BF4-4FDC-BC2B-B80D2DF07B7AQ57279635-5ECF3699-2AB2-4FC1-AFF7-6302667B45CAQ90194958-D56838B6-0A19-4D70-851E-17C09F6B7CED
P50
description
researcher ORCID ID = 0000-0003-1713-4788
@en
wetenschapper
@nl
name
Giuseppina Opinto
@ast
Giuseppina Opinto
@en
Giuseppina Opinto
@es
Giuseppina Opinto
@nl
type
label
Giuseppina Opinto
@ast
Giuseppina Opinto
@en
Giuseppina Opinto
@es
Giuseppina Opinto
@nl
prefLabel
Giuseppina Opinto
@ast
Giuseppina Opinto
@en
Giuseppina Opinto
@es
Giuseppina Opinto
@nl
P1153
55866704200
P21
P31
P496
0000-0003-1713-4788